Cresco Labs, Inc. (CRLBF)
0.6438
+0.01
(+1.23%)
USD |
OTCM |
Oct 09, 16:00
Cresco Labs Enterprise Value : 672.28M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 672.28M |
| October 08, 2026 | 669.37M |
| October 07, 2026 | 672.54M |
| October 06, 2026 | 670.86M |
| October 05, 2026 | 667.18M |
| October 02, 2026 | 682.00M |
| October 01, 2026 | 678.31M |
| September 30, 2026 | 670.49M |
| September 29, 2026 | 704.37M |
| September 28, 2026 | 715.51M |
| September 25, 2026 | 717.18M |
| September 24, 2026 | 711.75M |
| September 23, 2026 | 722.14M |
| September 22, 2026 | 726.64M |
| September 21, 2026 | 708.06M |
| September 18, 2026 | 711.82M |
| September 17, 2026 | 704.04M |
| September 16, 2026 | 704.37M |
| September 15, 2026 | 708.10M |
| September 14, 2026 | 708.88M |
| September 11, 2026 | 698.08M |
| September 10, 2026 | 703.78M |
| September 09, 2026 | 715.54M |
| September 08, 2026 | 715.54M |
| September 04, 2026 | 722.99M |
| Date | Value |
|---|---|
| September 03, 2026 | 708.54M |
| September 02, 2026 | 724.48M |
| September 01, 2026 | 711.82M |
| August 31, 2026 | 722.99M |
| August 28, 2026 | 720.29M |
| August 27, 2026 | 706.27M |
| August 26, 2026 | 708.10M |
| August 25, 2026 | 717.41M |
| August 24, 2026 | 722.99M |
| August 21, 2026 | 737.89M |
| August 20, 2026 | 729.51M |
| August 19, 2026 | 736.43M |
| August 18, 2026 | 730.40M |
| August 17, 2026 | 726.57M |
| August 14, 2026 | 719.79M |
| August 13, 2026 | 729.67M |
| August 12, 2026 | 719.27M |
| August 11, 2026 | 722.99M |
| August 10, 2026 | 703.78M |
| August 07, 2026 | 710.11M |
| August 06, 2026 | 700.65M |
| August 05, 2026 | 677.23M |
| August 04, 2026 | 693.24M |
| August 03, 2026 | 685.72M |
| July 31, 2026 | 671.46M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| cbdMD, Inc. | 4.431M |
| Trulieve Cannabis Corp. | 2.303B |
| ANI Pharmaceuticals, Inc. | 1.932B |
| Corcept Therapeutics, Inc. | 12.78B |
| Veru, Inc. | 18.84M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 15.37M |
| Revenue (Quarterly) | 173.34M |
| Total Expenses (Quarterly) | 156.54M |
| EPS Diluted (Quarterly) | 0.0356 |
| Gross Profit Margin (Quarterly) | 46.49% |
| Profit Margin (Quarterly) | 8.87% |
| Earnings Yield | -45.29% |
| Operating Earnings Yield | 34.93% |
| Normalized Earnings Yield | -4.349 |